Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity — Ya-Li Sang (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity
Shared by
De Clercq Erik
KU Leuven
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity
Article
2021
en
Authors
+2 more
YS
Ya-Li Sang
CP
Christophe Pannecouque
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs
Ping Gao
,
Shu Song
,
Zhao Wang
,
Lin Sun
,
Jian Zhang
,
Christophe Pannecouque
,
De Clercq Erik
,
Peng Zhan
,
Xinyong Liu
Article
2013
Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Xuwang Chen
,
Xin Liu
,
Qing Meng
,
Ding Wang
,
Huiqing Liu
,
De Clercq Erik
,
Christophe Pannecouque
,
Jan Balzarini
,
Xinyong Liu
Article
2018
Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the “NNRTI Adjacent” Binding Site
Dongwei Kang
,
Zhongxia Zhou
,
Gaochan Wu
,
Samuel Desta
,
Xiaofang Zuo
,
Zhao Wang
,
Lanlan Jing
,
Xiao Ding
,
Dirk Daelemans
,
De Clercq Erik
,
Christophe Pannecouque
,
Peng Zhan
,
Xinyong Liu
,
Zhipeng Huo
,
Heng Zhang
Article
2017
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs
Zhaoqiang Liu
,
Ye Tian
,
Jinghan Liu
,
Boshi Huang
,
Dongwei Kang
,
De Clercq Erik
,
Dirk Daelemans
,
Christophe Pannecouque
,
Peng Zhan
,
Xinyong Liu
Article
2023
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors
Xiangyi Jiang
,
Boshi Huang
,
Shawn Rumrill
,
David Pople
,
Waleed A. Zalloum
,
Dongwei Kang
,
Fabao Zhao
,
Xiangkai Ji
,
Zhen Gao
,
Lide Hu
,
Zhao Wang
,
Minghui Xie
,
De Clercq Erik
,
Francesc X. Ruiz
,
Eddy Arnold
,
Christophe Pannecouque
,
Xinyong Liu
,
Peng Zhan
Discussion(0)
No comments yet. Be the first to comment.